Therefore, we hypothesized that systemic buffering with oral NaHCO3 would enhance T- or NK-cell function and may thus synergize with anti-PD1 in treating transgenic mice with inducible MYC–driven HCC (27). Here, MYC is linked to hepatocellular carcinoma.